Batchelor D - Search Results

1

Treatment of disseminated renal cell cancer with combinations of interleukin-2, lymphokine-activated killer cells, and alpha-interferon.

Stoter G, Goey SH, Batchelor D, Eggermont AM, Lamers C, Gratama JW, Bolhuis RL. Stoter G, et al. Among authors: batchelor d. Prog Clin Biol Res. 1992;378:225-33. Prog Clin Biol Res. 1992. PMID: 1301583 Clinical Trial. No abstract available.

2

Repetitive weekly cycles of 4-day continuous infusion of recombinant interleukin-2: a phase I study.

Punt KC, Jansen RL, De Mulder PH, Batchelor D, Galazka A, Bolhuis RL, Stoter G. Punt KC, et al. Among authors: batchelor d. J Immunother (1991). 1992 Nov;12(4):277-84. doi: 10.1097/00002371-199211000-00009. J Immunother (1991). 1992. PMID: 1477079 Clinical Trial.

3

Interleukin-2-induced thyroid dysfunction is correlated with treatment duration but not with tumor response.

Kruit WH, Bolhuis RL, Goey SH, Jansen RL, Eggermont AM, Batchelor D, Schmitz PI, Stoter G. Kruit WH, et al. Among authors: batchelor d. J Clin Oncol. 1993 May;11(5):921-4. doi: 10.1200/JCO.1993.11.5.921. J Clin Oncol. 1993. PMID: 8487055

4

Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma.

de Gast GC, Klümpen HJ, Vyth-Dreese FA, Kersten MJ, Verra NC, Sein J, Batchelor D, Nooijen WJ, Schornagel JH. de Gast GC, et al. Among authors: batchelor d. Clin Cancer Res. 2000 Apr;6(4):1267-72. Clin Cancer Res. 2000. PMID: 10778950 Clinical Trial.

5

Infiltration of activated dendritic cells and T cells in renal cell carcinoma following combined cytokine immunotherapy.

Verra N, de Jong D, Bex A, Batchelor D, Dellemijn T, Sein J, Nooijen W, Meinhardt W, Horenblas S, de Gast G, Vyth-Dreese F. Verra N, et al. Among authors: batchelor d. Eur Urol. 2005 Sep;48(3):527-33. doi: 10.1016/j.eururo.2005.03.031. Epub 2005 Apr 11. Eur Urol. 2005. PMID: 16115526 Clinical Trial.

6

Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFN alpha in patients with metastatic melanoma.

de Gast GC, Batchelor D, Kersten MJ, Vyth-Dreese FA, Sein J, van de Kasteele WF, Nooijen WJ, Nieweg OE, de Waal MA, Boogerd W. de Gast GC, et al. Among authors: batchelor d. Br J Cancer. 2003 Jan 27;88(2):175-80. doi: 10.1038/sj.bjc.6600717. Br J Cancer. 2003. PMID: 12610499 Free PMC article.

7

The Dutch Cancer Society.

Batchelor D. Batchelor D. Eur J Cancer Care (Engl). 1999 Mar;8(1):16-8. doi: 10.1046/j.1365-2354.1999.00124.x. Eur J Cancer Care (Engl). 1999. PMID: 10362948 No abstract available.

8

Vlasveld LT, Rodenhuis S, Rutgers EJ, Dubbelman AC, Hilton AM, Batchelor D, Rankin EM. Vlasveld LT, et al. Among authors: batchelor d. Eur J Surg Oncol. 1994 Apr;20(2):122-9. Eur J Surg Oncol. 1994. PMID: 8181576

9

Oral topotecan: bioavailablity and effect of food co-administration.

Herben VM, Rosing H, ten Bokkel Huinink WW, van Zomeren DM, Batchelor D, Doyle E, Beusenberg FD, Beijnen JH, Schellens JH. Herben VM, et al. Among authors: batchelor d. Br J Cancer. 1999 Jul;80(9):1380-6. doi: 10.1038/sj.bjc.6690532. Br J Cancer. 1999. PMID: 10424739 Free PMC article. Clinical Trial.

10

Hair and cancer chemotherapy: consequences and nursing care--a literature study.

Batchelor D. Batchelor D. Eur J Cancer Care (Engl). 2001 Sep;10(3):147-63. doi: 10.1046/j.1365-2354.2001.00272.x. Eur J Cancer Care (Engl). 2001. PMID: 11829374 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters